2015–2020 Nomenclature and Labeling Expert Committee Work Plan

Contact

Andrzej Wilk, Ph.D., Senior Scientific Liaison - Healthcare Quality Standards, aw@usp.org

Interested in learning more about the work of this Expert Committee?

Download Roster Observe a Meeting

Upcoming Official Meetings

  • September 7, 2017 face-to-face meeting at USP–U.S., Rockville - Contact conferences@usp.org for more information.

Past Meetings – Executive Summaries

Latest Updates

Focus Areas

  • Nomenclature regulations and policies
  • Current marketplace products in respective focus areas
  • Labeling requirements
  • Analytical chemistry
  • Drug formulation specialist
  • Regulatory requirements

Expert Committee Charge

The Nomenclature and Labeling Expert Committee will review and approve monograph titles using practices developed by the Expert Committee elaborated in the USP Nomenclature Guidelines. Develop and revise general chapters (<7> Labeling, <1121> Nomenclature, <1091> Labeling of Inactive Ingredients) that focus on nomenclature and labeling topics. Review labeling statements in individual monographs.

Key Issues

  • Consistency of labeling statements throughout the USP–NF
  • Nomenclature of products containing salts
  • Nomenclature of Biologics
  • Nomenclature of Novel Dosage Forms
  • Nomenclature of Dietary Supplements and Excipients

Subcommittees, Joint Subcommittees, and Expert Panels

  • Dietary Supplements Herbal Medicines Nomenclature Joint Subcommittee
  • Excipients Nomenclature Joint Subcommittee
  • Labeling Subcommittee
  • Nomenclature for Biologics Joint Subcommittee
  • Ordering of Ingredients Subcommittee
  • Pronunciation Expert Panel

Ballot Results and Standards-Development